Literature DB >> 28474409

Amide proton transfer CEST of the cervical spinal cord in multiple sclerosis patients at 3T.

Samantha By1,2, Robert L Barry3,4, Alex K Smith1,2,5, Bailey D Lyttle2, Bailey A Box2, Francesca R Bagnato6, Siddharama Pawate6, Seth A Smith1,2,7.   

Abstract

PURPOSE: The ability to evaluate pathological changes in the spinal cord in multiple sclerosis (MS) is limited because T1 - and T2 -w MRI imaging are not sensitive to biochemical changes in vivo. Amide proton transfer (APT) chemical exchange saturation transfer (CEST) can indirectly detect amide protons associated with proteins and peptides, potentially providing more pathological specificity. Here, we implement APT CEST in the cervical spinal cord of healthy and MS cohorts at 3T.
METHODS: APT CEST of the cervical spinal cord was obtained in a cohort of 10 controls and 10 MS patients using a novel respiratory correction methodology. APT was quantified using two methods: 1) APTw , based off the conventional magnetization transfer ratio asymmetry, and 2) ΔAPT, a spatial characterization of APT changes in MS patients relative to the controls.
RESULTS: Respiratory correction yielded highly reproducible z-spectra in white matter (intraclass correlation coefficient = 0.82). APTw signals in normal-appearing white matter (NAWM) of MS patients were significantly different from healthy controls (P = 0.04), whereas ΔAPT of MS patients highlighted large APT differences in NAWM.
CONCLUSION: Respiration correction in the spinal cord is necessary to accurately quantify APT CEST, which can provide unique biochemical information regarding disease processes within the spinal cord. Magn Reson Med 79:806-814, 2018.
© 2017 International Society for Magnetic Resonance in Medicine. © 2017 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  CEST; amide proton transfer; multiple sclerosis; normal-appearing white matter; spinal cord

Mesh:

Substances:

Year:  2017        PMID: 28474409      PMCID: PMC5777527          DOI: 10.1002/mrm.26736

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  42 in total

1.  Amide proton transfer imaging of human brain tumors at 3T.

Authors:  Craig K Jones; Michael J Schlosser; Peter C M van Zijl; Martin G Pomper; Xavier Golay; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2006-09       Impact factor: 4.668

2.  In vivo three-dimensional whole-brain pulsed steady-state chemical exchange saturation transfer at 7 T.

Authors:  Craig K Jones; Daniel Polders; Jun Hua; He Zhu; Hans J Hoogduin; Jinyuan Zhou; Peter Luijten; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2011-11-14       Impact factor: 4.668

3.  Chemical exchange saturation transfer (CEST): what is in a name and what isn't?

Authors:  Peter C M van Zijl; Nirbhay N Yadav
Journal:  Magn Reson Med       Date:  2011-02-17       Impact factor: 4.668

4.  Imaging of glutamate in the spinal cord using GluCEST.

Authors:  Feliks Kogan; Anup Singh; Catherine Debrosse; Mohammad Haris; Kejia Cai; Ravi Prakash Nanga; Mark Elliott; Hari Hariharan; Ravinder Reddy
Journal:  Neuroimage       Date:  2013-04-09       Impact factor: 6.556

5.  Chemical exchange saturation transfer of the cervical spinal cord at 7 T.

Authors:  Adrienne N Dula; Siddharama Pawate; Lindsey M Dethrage; Benjamin N Conrad; Blake E Dewey; Robert L Barry; Seth A Smith
Journal:  NMR Biomed       Date:  2016-07-26       Impact factor: 4.044

6.  Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments.

Authors:  Mina Kim; Joseph Gillen; Bennett A Landman; Jinyuan Zhou; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2009-06       Impact factor: 4.668

7.  Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semi-solid magnetization transfer reference (EMR) signals: Application to a rat glioma model at 4.7 Tesla.

Authors:  Hye-Young Heo; Yi Zhang; Dong-Hoon Lee; Xiaohua Hong; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2015-03-05       Impact factor: 4.668

8.  Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination.

Authors:  J C J Bot; F Barkhof; C H Polman; G J Lycklama à Nijeholt; V de Groot; E Bergers; H J Ader; J A Castelijns
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

9.  Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T.

Authors:  Craig K Jones; Alan Huang; Jiadi Xu; Richard A E Edden; Michael Schär; Jun Hua; Nikita Oskolkov; Domenico Zacà; Jinyuan Zhou; Michael T McMahon; Jay J Pillai; Peter C M van Zijl
Journal:  Neuroimage       Date:  2013-04-06       Impact factor: 6.556

10.  Direct saturation MRI: theory and application to imaging brain iron.

Authors:  Seth A Smith; Jeff W M Bulte; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2009-08       Impact factor: 4.668

View more
  15 in total

1.  Prospective acceleration of parallel RF transmission-based 3D chemical exchange saturation transfer imaging with compressed sensing.

Authors:  Hye-Young Heo; Xiang Xu; Shanshan Jiang; Yansong Zhao; Jochen Keupp; Kristin J Redmond; John Laterra; Peter C M van Zijl; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2019-06-17       Impact factor: 4.668

2.  Monitoring diffuse injury during disease progression in experimental autoimmune encephalomyelitis with on resonance variable delay multiple pulse (onVDMP) CEST MRI.

Authors:  Aline M Thomas; Jiadi Xu; Peter A Calabresi; Peter C M van Zijl; Jeff W M Bulte
Journal:  Neuroimage       Date:  2019-10-09       Impact factor: 6.556

3.  Amide signal intensities may be reduced in the motor cortex and the corticospinal tract of ALS patients.

Authors:  Zhuozhi Dai; Sanjay Kalra; Dennell Mah; Peter Seres; Hongfu Sun; Renhua Wu; Alan H Wilman
Journal:  Eur Radiol       Date:  2020-09-09       Impact factor: 5.315

4.  Differentiation of Malignant and Benign Head and Neck Tumors with Amide Proton Transfer-Weighted MR Imaging.

Authors:  Lu Yu; Chunmei Li; Xiaojie Luo; Jinyuan Zhou; Chen Zhang; Yi Zhang; Min Chen
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

Review 5.  Chemical exchange saturation transfer magnetic resonance imaging and its main and potential applications in pre-clinical and clinical studies.

Authors:  Weiqiang Dou; Chien-Yuan Eddy Lin; Hongyuan Ding; Yong Shen; Carol Dou; Long Qian; Baohong Wen; Bing Wu
Journal:  Quant Imaging Med Surg       Date:  2019-10

6.  Evaluation of cell transplant-mediated attenuation of diffuse injury in experimental autoimmune encephalomyelitis using onVDMP CEST MRI.

Authors:  A M Thomas; S Li; C Chu; I Shats; J Xu; P A Calabresi; P C M van Zijl; P Walczak; J W M Bulte
Journal:  Exp Neurol       Date:  2020-04-15       Impact factor: 5.330

Review 7.  Opportunities for Molecular Imaging in Multiple Sclerosis Management: Linking Probe to Treatment.

Authors:  Aline M Thomas; Frederik Barkhof; Jeff W M Bulte
Journal:  Radiology       Date:  2022-04-26       Impact factor: 29.146

8.  Does the magnetization transfer effect bias chemical exchange saturation transfer effects? Quantifying chemical exchange saturation transfer in the presence of magnetization transfer.

Authors:  Alex K Smith; Kevin J Ray; James R Larkin; Martin Craig; Seth A Smith; Michael A Chappell
Journal:  Magn Reson Med       Date:  2020-02-18       Impact factor: 4.668

9.  Amide Proton Transfer Contrast Distribution in Different Brain Regions in Young Healthy Subjects.

Authors:  Thomas Sartoretti; Elisabeth Sartoretti; Michael Wyss; Árpád Schwenk; Arash Najafi; Christoph Binkert; Carolin Reischauer; Jinyuan Zhou; Shanshan Jiang; Anton S Becker; Sabine Sartoretti-Schefer
Journal:  Front Neurosci       Date:  2019-05-22       Impact factor: 4.677

Review 10.  Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in.

Authors:  Jeroen Van Schependom; Kaat Guldolf; Marie Béatrice D'hooghe; Guy Nagels; Miguel D'haeseleer
Journal:  Transl Neurodegener       Date:  2019-12-09       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.